Education
About Us
Working with TipRanks
Follow Us
Aardvark Therapeutics, Inc. (AARD)
:AARD
RESEARCH TOOLSreports
Morgan Stanley analyst Michael Ulz has reiterated their bullish stance on AARD stock, giving a Buy rating on March 31. Michael Ulz has given his Buy rating due to a
...Read more
AARD News on the Web
TipRanks News
Neutral
AAII
Neutral
AAII
Neutral
AAII
Neutral
AAII
Neutral
Zacks
Bullish
AAII
Neutral
AAII
Neutral
News Score - Last 7 Days
Media Buzz
This Week2 articles
Weekly Average2 articles
News Sentiment
This Week50%
Sector Average54%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines Media Buzz and News Sentiment.
This score is generated using a formula that combines Media Buzz and News Sentiment.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is AARD’s Media Buzz Sentiment?
2 articles about AARD were published this week. In an average week, 2 articles are published.
What is AARD’s weekly average amount of articles?
In an average week, 2 articles about AARD are published.
What is AARD’s News Sentiment?
50% of articles about AARD were positive this week, compared to its sector average of 54%.